Are EC-Japan-US Trade relations at the crossroads?

Cancer: A disease at the crossroads of trade‐offs

Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade-offs when allocating resources to competing life-history demands, such as growth, survival, and reproduction. These trade-offs are increasingly considered to be crucial to further our understanding of cancer. First, evidences suggest that neoplastic cells, as any living entities subject to natu...

The US FDA at a Crossroads (HRG Publication #1780)

Referring to the period prior to the establishment of the then Bureau of Chemistry in 1906 as the snake oil era may seem unkind, but it is not far from the mark. Few nostrums were effective, and fewer still had actual evidence of efficacy. Unrestricted claims of magical cures burst from the pages of newspapers and magazines, to the point that some of the most bellicose voices opposing advertisi...

Have US-Japan Trade Agreements Made a Difference?

The few existing empirical studies of U.S.-Japan trade agreements have relied primarily on descriptive statistics or univariate time series methods. We conduct a more powerful test by evaluating agreements in the context of well-specified econometric models. Consistent with trade theory, import demand is modeled as a cointegrating relationship with income and relative price variables, where a t...

Renal denervation: are we at a crossroads?

Since the first publication by Henry Krum in 2009 [1], it has been a bumpy road for renal denervation (RDN) for the treatment of sympathetic hyperactivity associated disease states, such as hypertension. After initial positive results of non-randomised and randomised trials, a true hype arose with more than 50 companies developing their own RDN system. The procedure was reimbursed in several co...

Editorial. At the crossroads.